Abstract: A water resistant connector assembly includes first and second connectors. Each connector has a housing and a water resistant seal. Each connector is formed in a two-shot operation with the housing being formed of polypropylene and the seal being formed of a thermoplastic elastomer. The seal of one of the connectors has a portion that is provided on an outer surface thereof and has ribs which fold over in a direction opposite a water ingression direction when the second connector is connected to the first convector, thereby creating a seal between the connectors when they are connected. The seals of each of the connectors are also provided at terminal/wire insertion areas, and these seals ensure proper insertion of the terminal/wires. These seals may further include strain relief portions to provide resistance to angularity of the wire.

Abstract: A connecter system is configured for macro motion. Two mating terminals are configured so that during macro motion cycles, the resistance between two terminals does not substantially increase. One terminal can have multiple, somewhat spherical-shaped mating surfaces while a mating surface on the other terminal can be flat. The mating terminals can be configured to provide desirable resistance performance after more than 5000 cycles of macro motion.

Abstract: Inhalation delivery of aerosols containing small particles from a device that forms drug containing aerosols for use in inhalation therapy. A device for delivering drug containing aerosols for inhalation therapy is provided. The device includes a housing and an airway that has a gas/vapor mixing airway. The airway further includes a subassembly, which has a metallic substrate coated on its surface with a composition comprising a drug.

Abstract: The present invention provides novel condensation aerosols for the treatment of disease and/or intermittent or acute conditions. These condensation aerosols have little or no pyrolysis degradation products and are characterized by having an MMAD of between 1-3 microns. These aerosols are made by rapidly heating a substrate coated with a thin film of drug having a thickness of between 0.05 and 20 ?m, while passing a gas over the film, to form particles of a desirable particle size for inhalation. Kits comprising a drug and a device for producing a condensation aerosol are also provided. The device contained in the kit typically, has an element for heating the drug which is coated as a film on the substrate and contains a therapeutically effective dose of a drug when the drug is administered in aerosol form, and an element allowing the vapor to cool to form an aerosol. Also disclosed, are methods for using these aerosols and kits.

Abstract: A portable modular target holding apparatus includes a base section, a pair of vertical support sections, each vertical support section of the pair of vertical support sections being connected to the base section, and a pair of target windows, each target window of the pair of target windows being connected to a respective vertical support section of the pair of vertical support sections. A target is removably connected to the each target window.

Abstract: The present application relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a method of forming an aerosol for use in inhalation therapy. The method involves: (a) heating a substrate coated with a composition of a drug to form a vapor, wherein the coated composition is in the form of a film less than 10? thick; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy. In another aspect, a method of forming an aerosol for use in inhalation therapy is provided, wherein the method involves: (a) heating a substrate coated with a composition of a drug to form a vapor in less than 100 milliseconds, wherein the vapor has a mass greater than 0.1 mg; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy.

Abstract: The present invention provides novel condensation aerosols for the treatment of disease and/or intermittent or acute conditions. These condensation aerosols have little or no pyrolysis degradation products and are characterized by having an MMAD of between 1-3 microns. These aerosols are made by rapidly heating a substrate coated with a thin film of drug having a thickness of between 0.05 and 20 ?m, while passing a gas over the film, to form particles of a desirable particle size for inhalation. Kits comprising a drug and a device for producing a condensation aerosol are also provided. The device contained in the kit typically, has an element for heating the drug which is coated as a film on the substrate and contains a therapeutically effective dose of a drug when the drug is administered in aerosol form, and an element allowing the vapor to cool to form an aerosol. Also disclosed, are methods for using these aerosols and kits.

Abstract: A method for creating new educational, and theme party products in the form of full color 3D paper napkin entities that resemble the entity that the napkin fold or origami fold is named for. Color patterns are applied to square paper napkins or serviettes which, with the like origami fold, creates a fun challenge to the individual folder to achieve the correct folded outcome. The paper napkins are both functional for everyday use, and are folding fun for seasonal & theme parties, birthdays, and are educational as they stimulate conversation and the creative mind while folding.

Abstract: The present disclosure relates to a compound of formula (I) or a salt thereof, wherein variable A, B, and X are as defined herein. The disclosure also relates to covalent conjugates of formula (II). The disclosure further relates to the use of the compounds of formula (I) and covalent conjugates of formula (II) in methods for detecting a change in the pH of a mixture.

Abstract: A method and device are provided to generate an aerosol having a desired particle sizes, i.e., from molecular to about 10 microns, which can be used to effectively deliver a physiologically active compound to organs and tissues such as the lung, eye, mucosa and skin. The aerosol is formed through vaporization of the compound while mixing the resulting vapor with a gas, in a ratio, to form the desired particle size when a stable concentration of particles in the gas is reached.

Abstract: A connector system is configured for macro motion. Two mating terminals are configured so that during macro motion cycles, the resistance between two terminals does not substantially increase. One terminal can have multiple, somewhat spherical-shaped mating surfaces while a mating surface on the other terminal can be flat. The mating terminals can be configured to provide desirable resistance performance after more than 5000 cycles of macro motion.

Abstract: The present application provides a connection device and a connector. The connector comprises a housing mounted on a circuit substrate and a plurality of terminals. The housing has a recessed region and a plurality of channels. The recessed region, together with the circuit substrate, forms a mating groove for mating a flexible circuit board, and the mating groove extends forwardly to a radius. The plurality of terminals correspond to the plurality of channels and each of the terminal includes a resilient contact arm. The resilient contact arm extends toward a surface of the circuit substrate in the corresponding channel of the housing and extends into the recessed region to form a contact portion. The connection device comprises the circuit substrate and the connector.

Abstract: The present invention provides novel condensation aerosols for the treatment of disease and/or intermittent or acute conditions. These condensation aerosols have little or no pyrolysis degradation products and are characterized by having an MMAD of between 1-3 microns. These aerosols are made by rapidly heating a substrate coated with a thin film of drug having a thickness of between 0.05 and 20 ?m, while passing a gas over the film, to form particles of a desirable particle size for inhalation. Kits comprising a drug and a device for producing a condensation aerosol are also provided, wherein the device, has an element for heating the drug which is coated as a film on the substrate and contains a therapeutically effective dose of a drug when the drug is administered in aerosol form, and an element allowing the vapor to cool to form an aerosol. Methods for use are also disclosed.

Abstract: A connector system includes a first connector with a housing. The housing supports a terminal with an aperture that is positioned adjacent a pocket. A ball is positioned in the pocket and is restrained by the terminal but is configured to partially extend through the aperture. A second connector includes a contact and a magnet attraction member. In operation, when the first and second connector are in a mated position, the ball is urged toward the magnetic attraction member due to a magnetic force and partially extends through the aperture so as to engage the contact, electrically connecting the terminal and the contact.

Abstract: A receptacle connector includes an insulative body, conductive terminals mounted therein, and a seal covering a central portion of the body. The receptacle connector mates with at least one mating electrical connector. The seal prevents the intrusion of dust into the joint between the receptacle connector and the mating electrical connector(s). The seal and the body have locking features provided thereon to secure the seal to the housing.

Abstract: The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a method of forming an aerosol for use in inhalation therapy. In a method aspect of the present invention, a method of forming an aerosol for use in inhalation therapy is provided.

Abstract: The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a method of forming an aerosol for use in inhalation therapy. The method involves: (a) heating a substrate coated with a composition comprising a drug to form a vapor, wherein the coated composition is in the form of a film less than 10? thick; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy. In another aspect, a method of forming an aerosol for use in inhalation therapy is provided, wherein the method comprises: (a) heating a substrate coated with a composition comprising a drug to form a vapor in less than 100 milliseconds, wherein the vapor has a mass greater than 0.1 mg; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy.

Abstract: A connector system includes a first connector with a housing. The housing supports a terminal with an aperture that is positioned adjacent a pocket. A ball is positioned in the pocket and is restrained by the terminal but is configured to partially extend through the aperture. A second connector includes a contact and a magnet attraction member. In operation, when the first and second connector are in a mated position, the ball is urged toward the magnetic attraction member due to a magnetic force and partially extends through the aperture so as to engage the contact, electrically connecting the terminal and the contact.

Abstract: A halogenated elastomer partially functionalized with triethylamine, in a mixture with fiiier and a cure package, suitable for use as an air barrier in an innertube or tire innerliner, is disclosed. The halogenated elastomer can be a polymer comprising C4 to C7 isoolefm derived units, para-alkylstyrene derived units, para-(haloalkylstyrene) derived units, and para-(triethylammoniumalkylstyrene) derived units. The Mooney viscosity of the elastomer can be controlled by the degree of triethylamine functionalization. Also disclosed is a method for making an article using the tri ethy iamine-functionalized elastomer.

Abstract: The present application provides a connection device and a connector. The connector comprises a housing mounted on a circuit substrate and a plurality of terminals. The housing has a recessed region and a plurality of channels. The recessed region, together with the circuit substrate, forms a mating groove for mating a flexible circuit board, and the mating groove extends forwardly to a radius. The plurality of terminals correspond to the plurality of channels and each of the terminal includes a resilient contact arm. The resilient contact arm extends toward a surface of the circuit substrate in the corresponding channel of the housing and extends into the recessed region to form a contact portion. The connection device comprises the circuit substrate and the connector.